{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:59:06Z","timestamp":1790863146610,"version":"4.1.0"},"reference-count":34,"publisher":"Georg Thieme Verlag KG","issue":"08","funder":[{"name":"Swedish Science Council","award":["(# 07143)"],"award-info":[{"award-number":["(# 07143)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2003]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The antithrombotic effect of bovine activated protein C (bAPC) given with or without bovine protein S (bPS) was investigated in a rat model of deep arterial injury. A segment of the left common carotid artery was isolated between vascular clamps and opened longitudinally. An endarterectomy was performed and the arteriotomy was closed with a running suture, whereafter the vessel was reperfused by removing the clamps. The antithrombotic effect (vascular patency rates 31 minutes after reperfusion) and the arteriotomy bleeding were measured. Ten treatment groups each containing 10 rats and a control group of 20 animals  were in a blind random fashion given intravenous bolus injections of increasing doses of activated protein C, with or without co-administration of protein S. The groups received either bAPC alone (0.8, 0.4, 0.2 or 0.1 mg\/kg), bAPC (0.8, 0.4, 0.2, 0.1 or 0.05 mg\/kg) combined with bPS (0.6 mg\/kg), or bPS alone (0.6 mg\/kg) whereas the control group received vehicle only. Administered alone, bAPC or bPS had no antithrombotic effect, regardless of dosage. In contrast, all groups that were treated with bAPC in combination with bPS demonstrated a significant antithrombotic effect, as compared to controls. Neither bAPC, bPS, nor the combination of bAPC and bPS increased the arteriotomy bleeding significantly compared to controls. In vitro clotting assays using bAPC or bPS alone yielded only minor prolongation of clotting time, whereas bAPC combined with bPS prolonged the clotting time considerably, demonstrating the dependence on the APC-cofactor activity of bPS for expression of anticoagulant activity by bAPC. In conclusion, our study shows the in vivo significance of protein S as a cofactor to activated protein C, and that potent anti-thrombotic effect can be achieved by low doses of bAPC combined with bPS, without producing hemorrhagic side effects.<\/jats:p>","DOI":"10.1160\/th03-03-0174","type":"journal-article","created":{"date-parts":[[2003,7,8]],"date-time":"2003-07-08T08:18:00Z","timestamp":1057652280000},"page":"227-234","source":"Crossref","is-referenced-by-count":7,"title":["Prevention of thrombosis following deep arterial injury in rats by bovine activated protein C requiring co-administration of bovine protein S"],"prefix":"10.1160","volume":"90","author":[{"given":"Bj\u00f6rn","family":"Dahlb\u00e4ck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Arnljots","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)02225-X","article-title":"Blood coagulation","volume":"355","author":"B Dahlback","year":"2000","journal-title":"Lancet"},{"key":"ref2","first-page":"614","article-title":"The Protein C Anticoagulant System. In: The Molecular Basis of Blood Diseases Stamatoyannopoulos, Majerus, Perlmutter, Varmus, eds","author":"B Dahlback","year":"2001"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0167-4838(99)00266-6","article-title":"Regulation of blood coagulation","volume":"1477","author":"CT Esmon","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0038-1650638","article-title":"Inherited thrombophilia: Part 1","volume":"76","author":"DA Lane","year":"1996","journal-title":"Thromb Haemost"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1055\/s-0038-1650673","article-title":"Inherited thrombophilia: Part 2","volume":"76","author":"DA Lane","year":"1996","journal-title":"Thromb Haemost"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"18735","DOI":"10.1016\/S0021-9258(17)32228-7","article-title":"Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa","volume":"269","author":"L Shen","year":"1994","journal-title":"J Biol Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1172\/JCI117883","article-title":"Protein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits","volume":"95","author":"B Arnljots","year":"1995","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/01.ATV.15.7.937","article-title":"Antithrombotic effects of activated protein C and protein S in a rabbit model of microarterial thrombosis","volume":"15","author":"B Arnljots","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0049-3848(81)90125-0","article-title":"Regulation of bovine activated protein C by protein S: the role of the cofactor protein in species specificity","volume":"22","author":"FJ Walker","year":"1981","journal-title":"Thromb Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"14884","DOI":"10.1016\/S0021-9258(18)68121-9","article-title":"Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection","volume":"263","author":"S Solymoss","year":"1988","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood.V77.12.2641.2641","article-title":"Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles","volume":"77","author":"G Tans","year":"1991","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1432-1033.1993.tb18314.x","article-title":"Molecular cloning, expression and functional characterization of rabbit anticoagulant vitamin-K-dependent protein S","volume":"217","author":"X He","year":"1993","journal-title":"Eur J Biochem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"27852","DOI":"10.1074\/jbc.270.46.27852","article-title":"Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C","volume":"270","author":"J Rosing","year":"1995","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"GR Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-0038-1648881","article-title":"Inhibition of microarterial thrombosis by activated protein C in a rabbit model","volume":"72","author":"B Arnljots","year":"1994","journal-title":"Thromb Haemost"},{"key":"ref16","first-page":"967","article-title":"Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis","volume":"295","author":"CV Jackson","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0037-1613843","article-title":"Inhibition of platelet thrombosis using an activated protein C-loaded stent: in vitro and in vivo results","volume":"83","author":"RS Foo","year":"2000","journal-title":"Thromb Haemost"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/01.CIR.90.1.427","article-title":"Prevention of arterial reocclusion after thrombolysis with activated protein C. Comparison with heparin in a canine model of coronary artery thrombosis","volume":"90","author":"T Sakamoto","year":"1994","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood.V73.3.639.639","article-title":"Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model","volume":"73","author":"A Gruber","year":"1989","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/01.CIR.82.2.578","article-title":"Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis","volume":"82","author":"A Gruber","year":"1990","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0049-3848(91)90194-2","article-title":"Inhibitory effects of activated protein C and heparin on thrombotic arterial occlusion in rat mesenteric arteries","volume":"62","author":"H Araki","year":"1991","journal-title":"Thromb Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0049-3848(94)90137-6","article-title":"The antithrombotic effect of human activated protein C on He-Ne laser- induced thrombosis in rat mesenteric microvessels","volume":"75","author":"T Yamashita","year":"1994","journal-title":"Thromb Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0049-3848(90)90082-N","article-title":"Low doses of activated protein C delay arterial thrombosis in rats","volume":"57","author":"MD Smirnov","year":"1990","journal-title":"Thromb Res"},{"key":"ref24","first-page":"80","article-title":"Enhanced thrombolysis induced by argatroban or activated protein C in the presence or absence of staphylokinase, measured in an in vivo animal model using mesenteric arterioles","volume":"31","author":"M Hashimoto","year":"2001","journal-title":"Haemostasis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0037-1612952","article-title":"Enhancement of endogenous plasminogen activator-induced thrombolysis by argatroban and APC and its control by TAFI, measured in an arterial thrombolysis model in vivo using rat mesenteric arterioles","volume":"87","author":"M Hashimoto","year":"2002","journal-title":"Thromb Haemost"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0021-9258(17)33886-3","article-title":"A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization","volume":"251","author":"J Stenflo","year":"1976","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-5793(79)81048-0","article-title":"Protein S, a new vitamin K-dependent protein from bovine plasma","volume":"101","author":"J Stenflo","year":"1979","journal-title":"FEBS Lett"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"18481","DOI":"10.1016\/S0021-9258(17)44777-6","article-title":"Novel type of very high affinity calcium-binding sites in beta- hydroxyasparagine-containing epidermal growth factor-like domains in vitamin K-dependent protein S","volume":"265","author":"B Dahlback","year":"1990","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1067\/mva.2001.112808","article-title":"Active site-inactivated factor VIIa prevents thrombosis without increased surgical bleeding: topical and intravenous administration in a rat model of deep arterial injury","volume":"33","author":"T Soderstrom","year":"2001","journal-title":"J Vasc Surg"},{"key":"ref30","first-page":"58","volume-title":"Microsurgery Practice Manual. In","author":"RD Acland","year":"1980"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1172\/JCI116452","article-title":"Tissue factor is rapidly induced in arterial smooth muscle after balloon injury","volume":"91","author":"JD Marmur","year":"1993","journal-title":"J Clin Invest"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1073\/pnas.86.8.2839","article-title":"Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque","volume":"86","author":"JN Wilcox","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","first-page":"1087","article-title":"Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis","volume":"134","author":"TA Drake","year":"1989","journal-title":"Am J Pathol"},{"issue":"05","key":"ref34","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/01.PRS.0000053549.45063.A1","article-title":"Low-molecular-weight heparin (Dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury","volume":"111","author":"K Malm","year":"2003","journal-title":"Plast Reconstr Surg"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1160\/TH03-03-0174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:18:28Z","timestamp":1685535508000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1160\/TH03-03-0174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":34,"journal-issue":{"issue":"08","published-online":{"date-parts":[[2017,12,6]]},"published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1160\/th03-03-0174","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003]]}}}